课题基金 / 基金详情

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
阿片类药物在美国的流行可以追溯到1980年的一封信
英文摘要
The opioid epidemic in the United States has been traced to a 1980 letter reporting in the prestigious New England Journal of Medicine that synthetic opioids are not addictive. A belated citation analysis led the journal to append this letter with a warning this letter has been “heavily and uncritically cited” as evidence that addiction is rare with opioid therapy.” This epidemic is but one example of how unreliable and uncritically cited scientific claims can affect public health, as studies from industry report that a substantial part of biomedical reports cannot be independently verified. Yet, there is no publicly available resource or indicator to determine how reliable a scientific claim is without becoming an expert on the subject or retaining one. The total citation count, the commonly used measure, is inherently a poor proxy for research quality because confirming and refuting citations are counted as equal, while the prestige of the journal is not a guarantee that a claim published there is true. The lack of indicators for the veracity of reported claims costs the public, businesses, and governments, billions of dollars per year. We have developed a prototype that automatically classifies statements citing a scientific claim into three classes: those that provide supporting or contradicting evidence, or merely mention the claim. This unique capability enables scite users to analyze the reliability of scientific claims at an unprecedented scale and speed, helping them to make better-informed decisions. The prototype has attracted potential customers among top biotechnology and pharmaceutical companies, research institutions, academia, and academic publishers. We propose to conduct research that will refine scite into an MVP by optimizing prototype efficiency and accuracy until they reach feasible milestones, and will refine the product-market fit in our beachhead market, academic publishing, whose influence on the integrity and reliability of research is difficult to overestimate.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/febs.15608
发表时间: 2021-07
期刊: The FEBS journal
影响因子: --
作者: [Nicholson JM, Uppala A, Sieber M, Grabitz P, Mordaunt M, Rife SC]
通讯作者: Rife SC
海外基金